Chemometric – assisted uv spectrophotometric method for determination of antihyperlipidemic agents in pharmaceutical formulation

Main Article Content

Santosh V Gandhi Amit S. Mutha

Abstract

This presented work is based on application of two multivariate calibration methods for simultaneous UV-VIS spectrophotometric determination of active substances in combined pharmaceutical formulation composed of Atorvastatin calcium (ATV) and Ezetimibe (EZT). The methods used were Principal Component Regression (PCR) and Partial Least Square (PLS). The Spectra of ATV and EZT were recorded at concentrations within their linear range 5.0-30.0 μg/ml for both drugs. 28 set of mixtures were used for calibration and 08 set of mixtures were used for validation in the wavelength range of 230 to 260 nm with the wavelength intervals λ= 0.5 nm in methanol. The methods were validated as per International Conference on HarmonizationQ2 (R1) (ICH) guidelines. These methods were successfully applied for determination of drugs in pharmaceutical formulation (tablet) with no interference of the excipient as indicated by the recovery study results. The proposed methods are simple, rapid and can be easily used as an alternative analysis tool in the quality control as well as in process control of drugs and formulation.

Article Details

How to Cite
GANDHI, Santosh V; MUTHA, Amit S.. Chemometric – assisted uv spectrophotometric method for determination of antihyperlipidemic agents in pharmaceutical formulation. Journal of Applied Pharmaceutical Research, [S.l.], v. 5, n. 2, p. 27-33, apr. 2017. ISSN 2348-0335. Available at: <http://japtronline.com/index.php/JOAPR/article/view/103>. Date accessed: 25 june 2017.
Keywords
Atorvastatin calcium, Ezetimibe, PLS, PCR, Validation
Section
Published Articles

References

[1] Salt/ester/formulation Atorvastatin Calcium for DB01076 (Atorvastatin): https://www.drugbank.ca/salts/DBSALT000011cited 21st December 2016.
[2] The Indian Pharmacopoeia. Vol. I, 1099-1100, (2014)
[3] Ezetimibe for DB00973: https://www.drugbank.ca/drugs/DB00973 cited 21st December 2016
[4] The Indian Pharmacopoeia. Vol. I, 1727-1728, (2014)
[5] Baldha R, Patel V and Bapna M. Simultaneous Spectrophotometric Determination of Atorvastatin Calcium and Ezetimibe in Tablet Dosage Form. International Journal of ChemTech Research, 1(2), 233-236 (2009)
[6] Kumar P, Ghosh A and Chaudhary M. Stability Indicating Method Development for Simultaneous Estimation of Ezetimibe and Atorvastatin in Pharmaceutical Formulations by RP-HPLC. Pharmaceut Anal Acta, 3(6), 1-6 (2012)
[7] Kumar S A, Debnath M, Seshagiri Rao JV and Sankar G D. Stability indicating RP-HPLC analytical method development and Validation for simultaneous estimation of Atorvastatin and Ezetimibe in bulk as well in pharmaceutical dosages form by using PDA detector. Scholar Research Library, 6(5), 37-55, (2014)
[8] V Rajamanickam, Rajasekaran, Stephen Rathinaraj and K Anandarajagopal. Development and Validation of Analytical Methods for Simultaneous Estimation of Atorvastatin Calcium and Ezetimibe in Combined Dosage Form. World Applied Sciences Journal, 9(12), 1424-1429, (2010)
[9] Kumar S A, Debnath M, Seshagiri Rao JV. New Validated RP – HPLC Analytical Method for Simultaneous Estimation of Atorvastatin and Ezetimibe in Bulk Samples as well in Tablet Dosage Forms by Using PDA Detector. Bentham Sciences, 11(4), 259-¬70, (2014)
[10] Miriam F A and N Magdy. Application of New Spectroflurometeric Determination Techniques for Determination of Atorvastatin and Ezetimibe Combined Tablet Dosage Form. Chem. Pharm. Bull., 63(6), 443-449, (2015)
[11] Dhaneshwar S S, Dhaneshwar S R, Deshpande P, and Patil M. Development and Validation of a Method for Simultaneous Densitometric Estimation of Atorvastatin Calcium and Ezetimibe as the Bulk Drug and in Tablet Dosage Forms. Acta Chromatographica, ,19, 141-148, (2007)
[12] Sonawane S S, Shirkhedkar A A, Fursule R A, Surana S J. Application of UV-Spectrophotometry and RP-HPLC for Simultaneous Determination of Atorvastatin Calcium and Ezetimibe in Pharmaceutical Dosage Form. Eurasian Journal of Analytical Chemistry, 1(1), 32-41, (2006)
[13] Saroj Kumar Raul, Atna Bhaskar Aravelli, Durgasi Jhansi. RP-Hplc Method Development and Validation for the Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form. Asian J Pharm Clin Res, 8, 178-181, (2015)
[14] Kumar S A, Debnath M, Seshagiri Rao JV and Sankar G D. New Validated Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Atorvastatin and Ezetimibe in Human Plasma by Using PDA Detector. Advanced Pharmaceutical Bulletin, 5(3), 385-391, (2015)
[15] Dinc E, Baleanu D. Spectrophotometric quantitative determination of cilazapriland hydrochlorothiazide in tablets by chemometric methods. Journal of Pharmaceutical and Biomedical Analysis, 30, 715–723, (2002)
[16] AzinJahangiri, KhosroAdibkia, Karim Asadpour-Zeynali, Yousef Javadzadeh, HamedHamishehkar, Mohammad Barzegar-Jalali. Application of Multivariate Calibration Methods, in Dissolution Testing and Simultaneous Determination of Atorvastatin and Ezetimibe in Their Combined Solid Dosage Form. Pharmaceutical Sciences, 22, 105-111, (2016)
[17] Bhaskar R, Sagar M, Saini V, Bhat M. UV-spectrophotometric-assisted chemometric methods for the simultaneous determination of metformin hydrochloride and gliclazide in pharmaceutical formulations. Pharmaceut Anal Acta, 3, 1-5, (2012)
[18] International Conference on Harmonization. ICH harmonized tripartite guideline validation of analytical procedures text and methodology Q2 (R1) ICH, Geneva, 1-17, (2005)